EQ-5D-5L | PROBE | Correlation | 95% CI |
Mobility | Q.9 Mobility aids | 0.42 | 0.35 to 0.47 |
Pain and discomfort | Q.10 Pain medications | 0.55 | 0.50 to 0.60 |
Q.11.1 Acute pain (activities) | 0.42 | 0.36 to 0.48 | |
Q.11.2 Acute pain (interference) | 0.39 | 0.32 to 0.45 | |
Q.12.1 Chronic pain (activities) | 0.56 | 0.51 to 0.61 | |
Q.12.2 Chronic pain (interference) | 0.57 | 0.52 to 0.62 | |
Self-care | Q.13 Activities of daily living | 0.65 | 0.61 to 0.69 |
Usual activities | Q.13 Activities of daily living | 0.71 | 0.67 to 0.74 |
Anxiety | N/A | N/A | N/A |
Utility index score | Total score | 0.67 | 0.62 to 0.71 |
EQ-5D-5L, EuroQol five dimension 5-level instrument; EQ-VAS, EuroQol visual analogue scale; N/A, not applicable; PROBE, Patient Reported Outcomes, Burdens and Experiences.